Dr. James Y. Wang Joins Epicutis as Chairman of the Scientific Advisory Board
Harvard-Trained Dermatologist Brings Expertise to Biotech Skin Health Brand
IRVINE, Calif., June 18, 2025 /PRNewswire/ -- Epicutis, a pioneering biotech skincare brand known for its science-backed, clean formulations that prioritize skin health over beauty, proudly announces the appointment of Dr. James Y. Wang as Chairman of its Scientific Advisory Board. As a Harvard and UCLA-trained double board-certified dermatologist and dermatopathologist, Dr. Wang brings a wealth of expertise in medical and aesthetic dermatology, reinforcing Epicutis' mission to deliver clinically advanced, non-toxic skincare solutions to market.
James Y. Wang, MD, Founder of Metropolis Dermatology, with five locations in California, is widely recognized as a leader in dermatology, specializing in the diagnosis and treatment of skin cancers, psoriasis, eczema, and acne. His impressive academic background includes graduating summa cum laude and Phi Beta Kappa in biology from Washington University in St. Louis, followed by earning his MD from Harvard Medical School and an MBA in healthcare policy from Harvard Business School.
'As a physician, I am committed to evidence-based skincare that is not only safe for all skin types but also effective,' shares Dr. Wang. 'Epicutis represents the perfect fusion of biotechnology and dermatological science, delivering formulations that truly transform skin health at a cellular level, and I am honored to contribute to this next chapter of innovation.'
Epicutis was founded on the principles of biotech-driven skincare, leveraging the research of Dr. Jeffrey Stock, a distinguished biophysicist and Princeton University professor. By harnessing proprietary, patented active ingredients, Epicutis formulates small-batch, high-performance skincare products available exclusively through skin professionals. With a focus on transparency, efficacy, and the elimination of unnecessary additives and stabilizers, the brand continues to set new standards in professional skincare.
'We are thrilled to have Dr. Wang join us as Chairman of our Scientific Advisory Board,' said Maxwell Stock, Founder and CEO of Epicutis. 'His deep understanding of dermatological science and passion for cutting-edge innovation align perfectly with our mission to clean up the skincare industry and support clinicians with science-backed, 100% non-toxic products that make a true impact on skin health.'
With Dr. Wang's leadership, Epicutis is advancing its commitment to safe, biotech-driven skincare solutions while championing higher regulation to ensure safety and efficacy in an industry often dominated by misleading marketing and mass production. By prioritizing science-backed formulations with patented, highly concentrated therapeutic ingredients, Epicutis is empowering skincare professionals to stand a chance against big beauty. More than just providing innovative products – the brand is actively investing in its partners' success, helping aesthetic businesses grow with exclusive, clinical-grade solutions that drive real results and build lasting patient trust.
For more information on Epicutis and its revolutionary approach to skincare, visit www.epicutis.com.
About Epicutis
Epicutis is a science-based, luxury professional skincare line that treats skin health and not age. Honoring a commitment to clean beauty and fewer ingredients, Epicutis offers science-based skincare using patented active ingredients in small-batch formulations created by expert formulator Masanori Tamura. Epicutis' novel ingredients are developed in-house by a team of scientists at Signum Biosciences utilizing technology discovered by Dr. Jeffry Stock at Princeton University. Signum Biosciences is a biopharmaceutical company focused on the discovery and development of innovative products to address major consumer and medical needs, and the development of compounds and botanical extracts that are mimetics of natural lipid ligands crucial to cellular regulation and signaling. To learn more about Epicutis, visit www.epicutis.com. To learn more about Signum Biosciences, visit www.signumbiosciences.com.
View original content to download multimedia: https://www.prnewswire.com/news-releases/dr-james-y-wang-joins-epicutis-as-chairman-of-the-scientific-advisory-board-302484174.html
SOURCE Epicutis Skincare
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
31 minutes ago
- Yahoo
Strong Portfolio Pushes SmartStop Self Storage REIT, Inc. (SMA) to Strong Buy
SmartStop Self Storage REIT, Inc. (NYSE:SMA) is among the best small company stocks to invest in. On Wednesday, analysts at Raymond James raised the price target for SmartStop Self Storage REIT, Inc. (NYSE:SMA) to $44.00, up from $42.00, while upgrading to Strong Buy from Outperform. This confidence is driven by the company's high-quality portfolio and operating platform. Over the last few months, SmartStop Self Storage REIT, Inc. (NYSE:SMA) has returned quite impressive returns. While the market's year-to-date return stands at merely 1.72%, the company reported an impressive 9.24%. This shows that the giant is just getting started. A row of self-storage units in a self-storage complex, showing the affordability and security offered by the company. From higher organic growth potential and margin upside to external growth impact because of its smaller size, the firm highlighted various reasons for a turnaround. The company has witnessed a revenue growth of 5.34% in the last twelve months, and with analysts anticipating 9% growth for the current fiscal year, SMA seems to be a hidden gem. SmartStop Self Storage REIT, Inc. (NYSE:SMA) is a California-based company that owns and operates self-storage facilities in the United States and Canada. This self-managed REIT has a fully integrated operations team of around 590 self-storage professionals. With 220 operating properties in 23 states, the company is committed to delivering value to its investors and customers. While we acknowledge the potential of SMA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
31 minutes ago
- Yahoo
Palantir, Meta, OpenAI, And Thinking Machines Just Had Their Executives Sworn Into The US Army Reserve
Four top tech executives have joined the U.S. Army Reserve as lieutenant colonels, skipping basic training and stepping directly into roles aimed at helping modernize the military. The initiative is part of a broader push by the Army to bring in private-sector innovation and reshape how the service approaches technology, talent, and modernization. The executives—Palantir (NYSE:PLTR) Chief Technology Officer Shyam Sankar, Meta (NASDAQ:META) CTO Andrew Bosworth, OpenAI Chief Product Officer Kevin Weil, and advisor at Thinking Machines Lab and former OpenAI Chief Research Officer Bob McGrew — will serve in a new unit called Detachment 201, also known as the Army's Executive Innovation Corps. Don't Miss: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — Peter Thiel turned $1,700 into $5 billion—now accredited investors are eyeing this software company with similar breakout potential. Learn how you can 'Detachment 201 is being created to bring in tech innovation executives to help the Army ... on broader conceptual things like talent management, how do we bring in tech-focused people into the ranks of the military, and then, how do we train them,' Army Chief of Staff spokesperson Col. Dave Butler, told Breaking Defense on June 13. Unlike traditional recruits, these executives will not attend boot camp. Instead, they will go through an express training program that covers marksmanship, physical fitness, Army history, and protocols. They will be expected to serve about 120 hours per year and pass annual fitness tests. 'You could think of it as a pilot' of a lighter version of basic training, Butler told Business Insider. The detachment's name, 201, references the HTTP status code indicating a newly created resource—a fitting metaphor for a new kind of Army asset. Trending: Maximize saving for your retirement and cut down on taxes: . According to an Army statement, the new officers will work on 'targeted projects to help guide rapid and scalable tech solutions to complex problems.' Their advisory roles will include input on AI-powered military systems and optimization tools for soldier fitness. However, safeguards will be in place to avoid conflicts of interest with their current or former employers. 'We've done this over and over when our nation needed top talent,' Butler told Breaking Defense. 'The difference is we used to do it in wartime. Now we're doing it ahead of wartime so that we can prepare and deter.' This marks another move by the Trump administration to align more closely with Silicon Valley. Palantir, Anduril, and other VC-backed defense tech startups have increasingly become major players in national security. Meta recently partnered with Anduril to develop augmented reality tools and AI systems for military direct commissioning has been used to bring in specialized talent, such as doctors or chaplains, during times of war. This move represents a peacetime shift aimed at long-term transformation. 'Their swearing-in is just the start of a bigger mission to inspire more tech pros to serve without leaving their careers,' the Army statement said. 'Showing the next generation how to make a difference in uniform.' Read Next: How do billionaires pay less in income tax than you?.UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? PALANTIR TECHNOLOGIES (PLTR): Free Stock Analysis Report This article Palantir, Meta, OpenAI, And Thinking Machines Just Had Their Executives Sworn Into The US Army Reserve originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.
Yahoo
31 minutes ago
- Yahoo
Cash Back Made Smarter with LendingClub's New Account
LendingClub Corporation (NYSE:LC) LendingClub Corporation (NYSE:LC) introduced LevelUp Checking, a new digital checking account that provides cash back on debit card purchases and personal loan repayments through its LendingClub Bank business. As part of its conditions, the account will offer 1% cash back on debit card purchases for mainly gas, groceries, and pharmacy products once its clients activate direct deposits. But it's more exciting for customers having a LendingClub Corporation (NYSE:LC) personal loan, as they can enjoy 2% cash back on their timely monthly loan payments using their LevelUp Checking account. As the Chief Customer Officer of LendingClub Corporation (NYSE:LC) stated, 'LevelUp Checking delivers cash back for essential purchases like gas and groceries while stacking on additional cash back for our borrowers who make on-time payments.' LendingClub Corporation (NYSE:LC) delivered around a 42% return in one year. While this may not be truly impressive, the recent insider buying can't be overlooked. During the five years of share price growth, the company has transitioned from loss to profitability. It's clear that the management's strategic vision will bring growth well into the future. LendingClub Corporation (NYSE:LC) is a California-based bank holding company that provides a variety of financial products and services in the United States. The core offerings of the company include deposit and loan products, as well as a lending marketplace platform. Incorporated in 2006, the small-cap company is focused on offering members better borrowing rates and higher savings yields. While we acknowledge the potential of LC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
